Pathology News and Research

RSS

Pathology is the study and diagnosis of disease through examination of organs, tissues, bodily fluids, and whole bodies (autopsies). The term also encompasses the related scientific study of disease processes, called General pathology. Medical pathology is divided in two main branches, Anatomical pathology and Clinical pathology. Veterinary pathology is concerned with animal disease whereas Phytopathology is the study of plant diseases.

LabCorp's first-quarter revenues increase by 3.3% to $1,193.6 million

Laboratory Corporation of America® Holdings today announced results for the quarter ended March 31, 2010.

21 Apr 2010

Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung cancer patients

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight® Dx Pulmotax™ assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC," included 368 samples from carcinoma patients.

21 Apr 2010

miRNAs may generate new insights on cancer and possible future treatments

Scientists are methodically unlocking the biological processes that lead to cancer, and recent discoveries with microRNAs (miRNAs) are revolutionizing their understanding and leading to clinical trials of potentially effective treatments.

21 Apr 2010

Duke University Medical Center, LabCorp form joint venture to commercialize new biomarkers

Duke University Medical Center and Laboratory Corporation of America Holdings announced today the formation of a joint venture to commercialize new biomarkers. The new entity is designed to speed the translation of newly discovered biomarkers into widely available clinical tools that can measure individual therapeutic responses, predict disease progression, and evaluate any number of biologic or disease-causing processes.

21 Apr 2010

Diagnosis of gastric adenomyoma remains a challenging issue

Gastric adenomyoma (AM) is a rare, benign tumor, characteristically composed of glands and cysts, lined by columnar, flattened epithelia and a prominent smooth muscle stroma. Patients with gastric AM may be asymptomatic, or present as nonspecific gastrointestinal symptoms.

21 Apr 2010

MUC1 expression indicates progression of pediatric inflammatory bowel disease

Millions of people are afflicted with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and 30 percent of new cases occur in childhood. Mucin 1, an epithelial mucin that has been shown to elicit both an immune response and to have altered glycosylation in disease, may be a noninvasive indicator of the progression of these illnesses.

20 Apr 2010

Striking down breast cancer related gene patent may not impact industry, says New York attorney

The recent decision in a Federal District Court in New York to strike down a patent for the breast cancer related BRCA-1 gene may not have the broad impact on the technology industry it had originally been feared to, says a New York attorney.

20 Apr 2010

Gamma-prime fibrinogen test can help better predict people at risk for heart attack

A simple blood test can identify people who are at risk for a heart attack, including thousands who don't have high cholesterol, according to researchers at Oregon Health & Science University.

20 Apr 2010

Hematological malignancies conference to provide update on blood-borne cancer

John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.

20 Apr 2010

Researchers use genistein to improve outlook of pancreatic cancer

Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented data at the American Association for Cancer Research's 101st Annual Meeting 2010 that shows when genistein, a component of soy, is paired with the FDA-approved drug oxaliplatin, pancreatic cancer cells become more sensitive to chemotherapy.

20 Apr 2010

UAB researchers discover four miRNAs to assess survival rate of colorectal cancer patients

Researchers at the University of Alabama at Birmingham Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.

20 Apr 2010

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.

19 Apr 2010

Biomarkers to help predict development of aggressive colorectal cancer discovered

Researchers at the University of Alabama at Birmingham (UAB) Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.

19 Apr 2010

First authoritative book on yawning

Yawning is a stereotyped phylogenetically ancient phenomenon that occurs in almost all vertebrates. As an emotional behavior and an expressive movement, yawning has many consequences; nevertheless, it has so far been poorly addressed in medical research and practice.

19 Apr 2010

Stanford researchers discover tissue-specific target in pathogen

A tumor-causing maize fungus with the unsavory-sounding name "corn smut" wields different weapons from its genetic arsenal depending on which part of the plant it infects. The discovery by Stanford researchers marks the first time tissue-specific targeting has been found in a pathogen.

19 Apr 2010

Ontario continues to have high quality laboratory testing and diagnostic systems: Lab MDs

April 18th-24th is National Medical Laboratory Professionals Week and Ontario's laboratory physicians want to emphasize that Ontario continues to have one of the safest, highest quality laboratory testing and diagnostic systems in the world.

17 Apr 2010

Updated clinical guidelines presented at EAU Anniversary Congress

A number of updated guidelines are presented at the Anniversary Congress of the European Association of Urology (EAU) held in Barcelona, from 16 through 20 April. The abridged versions - Pocket Guidelines - which are based on the extended text documents will also be available in Barcelona to all EAU members and press.

17 Apr 2010

Diabetic mice generate new insulin-producing cells following extreme cell destruction

Type 1 diabetes is the most common cause of diabetes in children, although it may occur at any age. Also called juvenile diabetes, this pathology usually results from autoimmune destruction of insulin-producing cells of the pancreas.

16 Apr 2010

Laquinimod may have neuroprotective properties in addition to anti-inflammatory effects for RRMS

Teva Pharmaceutical Industries Ltd. and Active Biotech today announced results from several studies demonstrating that laquinimod, a novel, investigational once-daily oral immunomodulator for relapsing remitting multiple sclerosis (RRMS) may have neuroprotective properties in addition to its anti-inflammatory effects.

16 Apr 2010

DNA modification can define early onset glioblastoma

A class of brain tumor that tends to emerge in younger patients but is less aggressive than others can be identified by examining DNA methylation of a specific set of genes, scientists at The University of Texas M. D. Anderson Cancer Center and colleagues with The Cancer Genome Atlas report today online at Cancer Cell.

16 Apr 2010

Pathology News and Research

Further Reading

LabCorp's first-quarter revenues increase by 3.3% to $1,193.6 million

Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung cancer patients

miRNAs may generate new insights on cancer and possible future treatments

Duke University Medical Center, LabCorp form joint venture to commercialize new biomarkers

Diagnosis of gastric adenomyoma remains a challenging issue

MUC1 expression indicates progression of pediatric inflammatory bowel disease

Striking down breast cancer related gene patent may not impact industry, says New York attorney

Gamma-prime fibrinogen test can help better predict people at risk for heart attack

Hematological malignancies conference to provide update on blood-borne cancer

Researchers use genistein to improve outlook of pancreatic cancer

UAB researchers discover four miRNAs to assess survival rate of colorectal cancer patients

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

Biomarkers to help predict development of aggressive colorectal cancer discovered

First authoritative book on yawning

Stanford researchers discover tissue-specific target in pathogen

Ontario continues to have high quality laboratory testing and diagnostic systems: Lab MDs

Updated clinical guidelines presented at EAU Anniversary Congress

Diabetic mice generate new insulin-producing cells following extreme cell destruction

Laquinimod may have neuroprotective properties in addition to anti-inflammatory effects for RRMS

DNA modification can define early onset glioblastoma

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News